Companies: 10,795·Total market cap: $144.5T
Kane Biotech Inc.

Kane Biotech Inc.

KNBIFOTCHealthcare● Active
$0.02
$-0.00(-7.80%)
Market Cap$3655326
P/E Ratio
52W High$0.048
52W Low$0.0201

Kane Biotech Inc. (KNBIF) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

knbif · market cap & enterprise value · FMP · as of Jun 8, 2026

Core market cap & key metrics

As of Jun 8, 2026, Kane Biotech Inc. (KNBIF) has a market cap — also referred to as its net worth or valuation — of $3,655,326, making it one of the top most valuable companies globally. Market Cap = $0.02 × shares outstanding.

Market Cap (Net Worth)$3,655,326knbif market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0knbif highest market cap ever
Stock Price$0.02OTC · Jun 8, 2026
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Kane Biotech Inc. (KNBIF) has a market cap — also referred to as its net worth or valuation — of $3,655,326 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Kane Biotech Inc. reached its all-time high market cap of $0 on —. Comparing the Kane Biotech Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Kane Biotech Inc. net worth vs peers and ask how Kane Biotech Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

KNBIF market cap · 6 questions

Kane Biotech Inc.'s net worth — measured as market capitalization — is $3,655,326 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$0.02 (price) × shares outstanding.

KNBIF net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.